Walking exercise + blood flow restriction

Walking exercise + blood flow restriction has been studied in 1 paper since 2026: 1 trial in people; 1 in the past year. The newest paper, Aug 13, 2026: “Walking with blood flow restriction in Parkinson's disease: vascular, neurotrophic and functional outcomes: a randomized controlled trial (WALK-BFR-PD Trial)”.

Intervention

1 paper studies it4 findingsUpdated

See all 1 papers on walking exercise + blood flow restriction

At a glance

The findings reach people, from one lab or study. 1 lab in 1 country.

“In contrast, WALK-BFR demonstrated significant improvements in BDNF and FMD (both p < 0.05)”
Walking with blood flow restriction in Parkinson's disease: vascular, neurotrophic and functional outcomes: a randomized controlled trial (WALK-BFR-PD Trial)European journal of applied physiology2026doi:10.1007/s00421-026-06395-3

None of its findings points the other way.

Humans: a single group. Cells, worms or flies and mice: nothing yet.
  • 1 lab in 1 country
  • Human trial1

Studies in people

1 study gave walking exercise + blood flow restriction to people and measured what changed.

What changedDesignPeopleSource

up: Increases BDNF

up: Improves flow-mediated dilation

up: Improves timed Up and Go test

Randomized trial8 weeks8 peopleParkinson's diseaseEuropean journal of applied physiology, Aug 13, 2026

What did studies of walking exercise + blood flow restriction find?

4

Studies of walking exercise + blood flow restriction measured 4 outcomes, among them Parkinson's disease, timed Up and Go test and flow-mediated dilation.

Parkinson's disease

downin humans1

1 study
  1. Walking exercise + blood flow restriction decreases Parkinson's disease in humans (Parkinson's disease).

    “and total UPDRS scores, with additional reductions in UPDRS Parts II-IV”

    Human trialParkinson's disease8 weeksn = 8

    Walking with blood flow restriction in Parkinson's disease: vascular, neurotrophic and functional outcomes: a randomized controlled trial (WALK-BFR-PD Trial)

    European journal of applied physiology

More on Parkinson's disease

Timed Up and Go test

upin humans1

1 study
  1. Walking exercise + blood flow restriction improves timed Up and Go test in humans (Parkinson's disease).

    “as well as functional performance (TUGT and 10MWT), quality of life (PDQ-8), and total UPDRS scores”

    Human trialParkinson's disease8 weeksn = 8

    Walking with blood flow restriction in Parkinson's disease: vascular, neurotrophic and functional outcomes: a randomized controlled trial (WALK-BFR-PD Trial)

    European journal of applied physiology

Flow-mediated dilation

upin humans1

1 study
  1. Walking exercise + blood flow restriction improves flow-mediated dilation in humans (Parkinson's disease).

    “In contrast, WALK-BFR demonstrated significant improvements in BDNF and FMD (both p < 0.05)”

    Human trialParkinson's disease8 weeksn = 8

    Walking with blood flow restriction in Parkinson's disease: vascular, neurotrophic and functional outcomes: a randomized controlled trial (WALK-BFR-PD Trial)

    European journal of applied physiology

More on Flow-mediated dilation

BDNF

upin humans1

1 study
  1. Walking exercise + blood flow restriction increases BDNF in humans (Parkinson's disease).

    “In contrast, WALK-BFR demonstrated significant improvements in BDNF and FMD (both p < 0.05)”

    Human trialParkinson's disease8 weeksn = 8

    Walking with blood flow restriction in Parkinson's disease: vascular, neurotrophic and functional outcomes: a randomized controlled trial (WALK-BFR-PD Trial)

    European journal of applied physiology

More on BDNF

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 1Sep 2026: 0Oct 2026: 0Nov 2026: 01 paper in 12 months